A Phase 1 clinical trial is evaluating an investigational vaccine designed to protect against coronavirus disease in Seattle.
The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccineon Monday, March 16th.
The study is evaluating different doses of the experimental vaccine for safety, and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.
The investigational vaccine was developed using a genetic platform called mRNA. The investigational vaccine directs the body’s cells to express a virus protein that it is hoped will elicit a robust immune response.
The mRNA-1273 vaccine has shown promising results in animal models, and this is the first tiem it will be used on humans.
The Yucatan Times
more recommended stories
Rabies Vaccination Campaign in Progreso, Yuc.
Progreso, Yucatán (February 26, 2021).- This.
Poland opens murder investigation into fate of 2 Polish nationals in Mexico
WARSAW, Poland (Thu, February 25, 2021).
Is Quintana Roo’s tourist corridor becoming a place of operation for drug traffickers?
Recent high-profile drug plane interceptions suggest.
First Account Surplus in decades for Mexico during 2020
(Reuters).- Mexico registered an annual current.
Banco de Mexico is ready to help Financial Markets operate “smoothly”
MEXICO CITY (REUTERS) – Mexico’s central bank.
Is AMLO trying to break with the USMCA?
Ahead of Blinken meeting, Mexico president.
Bill Gates to AMLO: more education and less oil
Bill Gates reveals that if he.
Chichén Itzá will close for the second year during the Spring Equinox
Chichén Itzá will reopen its doors.
FBI Confirms Report of ‘Long, Cylindrical’ UFO ‘Moving Really Fast’ Over New Mexico
American Airlines pilots encountered a strange UFO over New Mexico..
Mayoral candidate executed by “sicario” in Puerto Morelos
The official under the command of.